[Organizational and financial aspects of the introduction of Botox® in the clinical diagnostic therapeutic process of chronic migraine at a Local Health Unit in Italy]. FE [Internet]. 2016 Oct. 20 [cited 2025 Oct. 29];17(3). Available from: https://journals.seedstm.com/index.php/FE/article/view/1262